Skip to main content
TipRanks
Go Ultimate75% OFF

Benjamin Hohl Insider Profile

4 Followers

Benjamin Hohl, CFO at Enliven Therapeutics, holds 38.00K shares in Enliven Therapeutics (Ticker: ELVN).

Benjamin Hohl's Trading History

ELVN
Enliven Therapeutics
Oct 21, 2026CFOUninformative Buy89.37K$1.95M
ELVN
Insider Shares: 38.00K (0.05%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 21, 2026Uninformative Sell$231.51K6,018$38.47―
Oct 21, 2026Uninformative Buy$89.37K6,018$14.85―
Sep 21, 2026Uninformative Sell$302.96K6,018$50.34―
Sep 21, 2026Uninformative Buy$59.13K3,982$14.85―
Aug 19, 2026Uninformative Sell$352.54K6,018$58.58―

You May Also Like

Benjamin Hohl insider profile FAQ

What stocks does Benjamin Hohl hold?
Benjamin Hohl holds: ELVN stocks.
What was Benjamin Hohl’s latest transaction?
Benjamin Hohl’s latest transaction was an Uninformative Buy of $89.37K.
What is Benjamin Hohl's role in Enliven Therapeutics?
Benjamin Hohl's role in Enliven Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.